Taylor Andrew Lawrence 4
4 · Orchestra BioMed Holdings, Inc. · Filed Aug 8, 2025
Insider Transaction Report
Form 4
Taylor Andrew Lawrence
Chief Financial Officer
Transactions
- Award
Common Stock, par value $0.0001 per share ("Common Stock")
2025-08-07+80,000→ 480,788 total
Footnotes (1)
- [F1]Represents an award of restricted stock units ("RSUs") to the Reporting Person on August 7, 2025 (the "Grant Date"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 33.33% of the shares will vest 24 months after the Grant Date, (ii) 33.33% of the shares will vest 30 months after the Grant Date, and (iii) 33.34% of the shares will vest 36 months after the Grant Date, subject to the Reporting Person's continuous service through such dates.